First, let’s remind ourselves what was known about potential adverse events before any Covid-19 vaccine was administered to the general public:
aaronsiri V-Safe Part 2: What Is V-Safe? What Data Does It Contain? Did It Ask About the Known Serious Potential Harms? And Why You Should Care!
- A July 2020 New England Journal of Medicine study titled “An mRNA Vaccine against SARS-Cov-2 – Preliminary Report” highlighted 35 adverse events that were related to the mRNA vaccination, including eye disorders, gastrointestinal disorders, musculoskeletal and connective tissue disorders, and nervous system disorders.
- An October 16, 2020 JAMA article titled “Postapproval Vaccine Safety Surveillance for COVID-19 Vaccines in the US” stated that “AESIs [Adverse Events of Special Interest] are likely to include allergic, inflammatory, and immune-mediated reactions, such as anaphylaxis, Guillain-Barré syndrome, transverse myelitis, myocarditis/pericarditis, vaccine-associated enhanced respiratory disease, and multisystem inflammatory syndrome in children.”
- In a CDC presentation dated October 30, 2020, titled “CDC post-authorization/post-licensure safety monitoring of COVID-19 vaccines,” a preliminary “list of VSD pre-specified outcomes for RCA [rapid cycle analysis]” and “list of VAERS AEs[ adverse events] of special interest” both included acute myocardial infarction, anaphylaxis, convulsions/seizures, encephalitis, Guillain-Barre syndrome, immune thrombocytopenia, MIS-C, myocarditis/pericarditis, and transverse myelitis, among others.
None of the above were asked about nor disclosed inside of the V Safe program…. why not?